Released juvenile animal reports exhibit that the administration of anesthetic and sedation drugs, which include Pentobarbital Sodium Injection USP, (Nembutal) that possibly block NMDA receptors or potentiate the activity of GABA through the duration of swift brain progress or synaptogenesis, ends in common neuronal and oligodendrocyte mobile loss